Clinical factors to help decide between angioplasty and carotid endarterectomy

Original title: A clinical rule (sex, contralateral occlusion, age, and restenosis) to select patients for stenting versus carotid endarterectomy: Systematic review of observational studies with validation in randomized trials. Reference: Touzé E et al. Stroke. 2013;Epub ahead of print

Compared with carotid endarterectomy, angioplasty with stent is associated with an increased risk of pre- procedural stroke especially for patients with symptomatic stenosis. However, after passing the pre-procedure, the long-term risk is similar between the two methods suggesting that both procedures may be appropriate for different patients instead of competing.

First this work was a systematic review of observational studies (170 studies) that evaluated the risk factors to present events for both carotid endarterectomy and angioplasty. We found nine key factors: age, contralateral carotid occlusion, coronary heart disease, diabetes, sex, hypertension, peripheral arterial disease and finally type and side of the obstruction. We calculated the relative risks of each factor for stroke and death by identifying those with different effect as endarterectomy or angioplasty making a rule that was validated with randomized studies.

Contralateral occlusion and female gender are associated with an increased risk of stroke and carotid endarterectomy death but have not a significant influence in angioplasty. Those with restenosis caused by endarterectomy also shown at increased risk in a second surgery unlike angioplasty. Age was associated with an increased risk for both procedures but especially for angioplasty. Thus arose the four fundamental factors that were the basis for the rule named by researchers SCAR (the acronym for the 4 factors: Sex, Contralateral occlusion, Age, and Restenosis).

The relative risk of events with angioplasty versus surgery in patients negative SCAR was 0.93 (0.49 to 1.76, P = 0.83) as opposed to those with positive SCAR was 2.44 (1.71 to 3.48, P < 0.0001).

The rule was validated in 3 large randomized studies (EVA – 3S, SPACE, and ICSS) with a total of 3049 patients. Of the total, 694 patients (22.8 %) were classified as negative SCAR meaning had contralateral occlusion, restenosis, and female less than 75 years. In those with negative SCAR the absolute risk of any stroke or death was identical between surgery or angioplasty (5.6 % ) in contrast to patients with positive SCAR where angioplasty presented twice the events compared to surgery (8.4 % versus 3.5 % ). 

Conclusion: 

The rule SCAR is potentially useful to identify those patients in whom carotid angioplasty has a similar risk of stroke or death than endarterectomy. 

Editorial comment:

While this rule may be considered useful yet to be tested prospectively and possibly refined. The results of this study are contrary to those of a recent analysis of the CREST study where women had a higher risk of events with angioplasty than men (5.5 % versus 3.7 % ) 

SOLACI.ORG

More articles by this author

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

TCT 2024 | PEERLESS: Mechanical Thrombectomy with FlowTriever vs Catheter-Directed Thrombolysis in Intermediate Risk PTE

Pulmonary embolism (PE) continues to be the third cause of cardiovascular mortality. The current clinical guidelines recommend anticoagulation in intermediate risk patients presenting right...

Atherosclerotic Renal Artery Stenosis: To Revascularize or Not

At long term, atherosclerotic renal artery stenosis (RAS) can lead to hypertension, chronic kidney disease, and cardiac failure. Historically, these patients have been referred...

Endovascular Management of Chronic TEPH: Is Coronary Management Extrapolatable in This Scenario?

Chronic thromboembolic pulmonary hypertension (CTEPH) is a condition that causes significant functional limitation. Its surgical treatment, known as pulmonary endarterectomy (PEA), has improved the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...